These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37702017)

  • 1. The frontline of alternatives to animal testing: novel in vitro skin model application in drug development and evaluation.
    Zhao H; Chen Z; Kang X; Yang B; Luo P; Li H; He Q
    Toxicol Sci; 2023 Nov; 196(2):152-169. PubMed ID: 37702017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT).
    Costin GE; Hill E; Brown J; Clippinger AJ
    Toxicol In Vitro; 2020 Feb; 62():104680. PubMed ID: 31626901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh.
    Kolle SN; Landsiedel R
    Handb Exp Pharmacol; 2021; 265():3-27. PubMed ID: 33136188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for skin irritation testing.
    Robinson MK; Perkins MA
    Am J Contact Dermat; 2002 Mar; 13(1):21-9. PubMed ID: 11887101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECVAM and new technologies for toxicity testing.
    Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
    Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of primary eye and skin irritants by in vitro cytotoxicity and phototoxicity models: an in vitro approach of new arginine-based surfactant-induced irritation.
    Benavides T; Mitjans M; Martínez V; Clapés P; Infante MR; Clothier RH; Vinardell MP
    Toxicology; 2004 May; 197(3):229-37. PubMed ID: 15033545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro models for evaluating safety and efficacy of novel technologies for skin drug delivery.
    Planz V; Lehr CM; Windbergs M
    J Control Release; 2016 Nov; 242():89-104. PubMed ID: 27612408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.
    Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V
    Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ready-to-use integrated in vitro skin corrosion and irritation testing strategy using EpiSkin™ model in China.
    Liu Y; Li N; Chen L; Alépée N; Cai Z
    Toxicol In Vitro; 2020 Jun; 65():104778. PubMed ID: 31962199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of human epidermal model LabCyte EPI-MODEL for in vitro skin irritation testing according to European Centre for the Validation of Alternative Methods (ECVAM)-validated protocol.
    Katoh M; Hamajima F; Ogasawara T; Hata K
    J Toxicol Sci; 2009 Jun; 34(3):327-34. PubMed ID: 19483386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity evaluation of the photoprotective compound LQFM048: Eye irritation, skin toxicity and genotoxic endpoints.
    de Ávila RI; de Sousa Vieira M; Gaeti MP; Moreira LC; de Brito Rodrigues L; de Oliveira GA; Batista AC; Vinhal DC; Menegatti R; Valadares MC
    Toxicology; 2017 Feb; 376():83-93. PubMed ID: 27129947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2007 Dec; 35(6):673-82. PubMed ID: 18186672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a mechanistic SAR model for the detection of phototoxic chemicals and use in an integrated testing strategy.
    Ringeissen S; Marrot L; Note R; Labarussiat A; Imbert S; Todorov M; Mekenyan O; Meunier JR
    Toxicol In Vitro; 2011 Feb; 25(1):324-34. PubMed ID: 20932893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the potential irritation and photoirritation of novel amino acid-based surfactants by in vitro methods as alternative to the animal tests.
    Benavides T; Martínez V; Mitjans M; Infante MR; Moran C; Clapés P; Clothier R; Vinardell MP
    Toxicology; 2004 Sep; 201(1-3):87-93. PubMed ID: 15297023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative methods for eye and skin irritation tests: an overview.
    Vinardell MP; Mitjans M
    J Pharm Sci; 2008 Jan; 97(1):46-59. PubMed ID: 17701961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fibrin-based dermal-epidermal organotypic cultures for in vitro skin corrosion and irritation testing of chemicals according to OECD TG 431 and 439.
    Morales M; Pérez D; Correa L; Restrepo L
    Toxicol In Vitro; 2016 Oct; 36():89-96. PubMed ID: 27448499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated testing strategy for in vitro skin corrosion and irritation assessment using SkinEthic™ Reconstructed Human Epidermis.
    Alépée N; Grandidier MH; Tornier C; Cotovio J
    Toxicol In Vitro; 2015 Oct; 29(7):1779-92. PubMed ID: 26187475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin2--an in vitro human skin model: the correlation between in vivo and in vitro testing of surfactants.
    Demetrulias J; Donnelly T; Morhenn V; Jessee B; Hainsworth S; Casterton P; Bernhofer L; Martin K; Decker D
    Exp Dermatol; 1998 Feb; 7(1):18-26. PubMed ID: 9517918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-animal testing strategies for assessment of the skin corrosion and skin irritation potential of ingredients and finished products.
    Robinson MK; Cohen C; de Fraissinette Ade B; Ponec M; Whittle E; Fentem JH
    Food Chem Toxicol; 2002 May; 40(5):573-92. PubMed ID: 11955663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.